Skip to content
Back to meeting Original
UroToday.com· @urotoday · X·· 5 hours agoScore70

VOLGA

Body

Is Less Enough and More Too Much? Implications of #VOLGA for the Peri-Operative Therapeutic Landscape in MIBC. Presented by @MichvdHeijden @NKI_nl. #ESMO26 written coverage by @chavarriagaj @PSH_Urology > https://bit.ly/4spmJHt #BladderCancer #MIBC #Immunotherapy @myESMO

49 views · 3 likes · 1 repost · 0 replies

Conference abstracts
LBA2matched by Presidential Symposium I

Perioperative durvalumab with or without tremelimumab plus neoadjuvant enfortumab vedotin in muscle-invasive bladder cancer: Results from the phase 3 VOLGA trial

https://esmocongress.esmo.org

Source: UroToday.com · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org

Disclaimer CBA Frontier Insights uses AI-assisted methods to aggregate, summarize, and analyze publicly accessible biopharmaceutical information. Content is provided for informational and educational purposes only and does not represent the official views of original sources or affiliated organizations. AI-generated content may contain errors; please verify important information against primary sources. Intellectual property rights remain with their respective owners. For copyright concerns or corrections, please contact us through the website’s feedback page.